Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0310
-0.0020 (-6.06%)
Oct 9, 2026, 4:10 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 3.65 million as of October 9, 2026. It is the 47,344th most valuable company in the world and the 1,609th biggest in Australia. Its market cap has decreased by 50.02% in one year.
Market Cap
3.65M
Enterprise Value
13.10M
Revenue
161.19K
Global Rank
Country Rank
#1,609 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 3.65M, an increase of 17.20%. That is a compound annual growth rate of 1.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 3.65M | -37.40% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syntara | 41.22M |
| Peak Processing | 21.43M |
| IDT Australia | 16.24M |
| Vitura Health | 12.59M |
| Epsilon Healthcare | 10.12M |
| Cann Group | 9.96M |
| ECS Botanics Holdings | 9.61M |
| Percheron Therapeutics | 7.29M |